These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
335 related articles for article (PubMed ID: 11966706)
21. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions. Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754 [TBL] [Abstract][Full Text] [Related]
22. Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies. Hacker MK; Janson M; Fairley JA; Lin MS Clin Immunol; 2002 Oct; 105(1):64-74. PubMed ID: 12483995 [TBL] [Abstract][Full Text] [Related]
23. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus. Mentink LF; de Jong MC; Kloosterhuis GJ; Zuiderveen J; Jonkman MF; Pas HH Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817 [TBL] [Abstract][Full Text] [Related]
24. Two cases of cutaneous-type pemphigus vulgaris and a case of pemphigus foliaceus without mucosal involvement despite high anti-desmoglein 3 autoantibody levels. Terada A; Akasaka E; Nakano H; Sawamura D J Dermatol; 2023 Nov; 50(11):1501-1505. PubMed ID: 37485682 [TBL] [Abstract][Full Text] [Related]
25. Pemphigus herpetiformis: analysis of the autoantibody profile during the disease course with changes in the clinical phenotype. Lebeau S; Müller R; Masouyé I; Hertl M; Borradori L Clin Exp Dermatol; 2010 Jun; 35(4):366-72. PubMed ID: 19874319 [TBL] [Abstract][Full Text] [Related]
26. Herpetiform pemphigus showing reactivity with pemphigus vulgaris antigen (desmoglein 3). Kubo A; Amagai M; Hashimoto T; Doi T; Higashiyama M; Hashimoto K; Yoshikawa K Br J Dermatol; 1997 Jul; 137(1):109-13. PubMed ID: 9274636 [TBL] [Abstract][Full Text] [Related]
27. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. Amagai M; Nishikawa T; Nousari HC; Anhalt GJ; Hashimoto T J Clin Invest; 1998 Aug; 102(4):775-82. PubMed ID: 9710446 [TBL] [Abstract][Full Text] [Related]
28. Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus. Futei Y; Amagai M; Ishii K; Kuroda-Kinoshita K; Ohya K; Nishikawa T J Dermatol Sci; 2001 May; 26(1):55-61. PubMed ID: 11323221 [TBL] [Abstract][Full Text] [Related]
29. Evaluating efficacy of plasmapheresis for patients with pemphigus using desmoglein enzyme-linked immunosorbent assay. Nagasaka T; Fujii Y; Ishida A; Handa M; Tanikawa A; Amagai M; Nishikawa T Br J Dermatol; 2008 Apr; 158(4):685-90. PubMed ID: 18241273 [TBL] [Abstract][Full Text] [Related]
30. Serum and salivary desmoglein 1 and 3 enzyme-linked immunosorbent assay in pemphigus vulgaris: correlation with phenotype and severity. Hallaji Z; Mortazavi H; Lajevardi V; Tamizifar B; AmirZargar A; Daneshpazhooh M; Chams-Davatchi C J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):275-80. PubMed ID: 19709345 [TBL] [Abstract][Full Text] [Related]
31. A case of herpetiform pemphigus with anti-desmoglein 3 IgG autoantibodies. Isogai R; Kawada A; Aragane Y; Amagai M; Tezuka T J Dermatol; 2004 May; 31(5):407-10. PubMed ID: 15187309 [TBL] [Abstract][Full Text] [Related]
32. Role of Dsg1- and Dsg3-Mediated Signaling in Pemphigus Autoantibody-Induced Loss of Keratinocyte Cohesion. Walter E; Vielmuth F; Wanuske MT; Seifert M; Pollmann R; Eming R; Waschke J Front Immunol; 2019; 10():1128. PubMed ID: 31178865 [TBL] [Abstract][Full Text] [Related]
33. A comparison of anti-desmoglein antibodies and indirect immunofluorescence in the serodiagnosis of pemphigus vulgaris. Zagorodniuk I; Weltfriend S; Shtruminger L; Sprecher E; Kogan O; Pollack S; Bergman R Int J Dermatol; 2005 Jul; 44(7):541-4. PubMed ID: 15985020 [TBL] [Abstract][Full Text] [Related]
34. Correlation between salivary and serum anti-desmoglein 1 and 3 antibody titres using ELISA and between anti-desmoglein levels and disease severity in pemphigus vulgaris. De D; Khullar G; Handa S; Joshi N; Saikia B; Minz RW Clin Exp Dermatol; 2017 Aug; 42(6):648-650. PubMed ID: 28543318 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of sensitivity and specificity of enzyme-linked immunosorbent assay (ELISA) for detecting antidesmoglein 1 and 3 in Thai patients with pemphigus vulgaris and foliaceus. Kulkollakarn S; Wattanakrai P; Vachiramon V; Chalidapongse P J Med Assoc Thai; 2008 Nov; 91(11):1663-8. PubMed ID: 19127786 [TBL] [Abstract][Full Text] [Related]
36. Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool. Lenz P; Amagai M; Volc-Platzer B; Stingl G; Kirnbauer R Arch Dermatol; 1999 Feb; 135(2):143-8. PubMed ID: 10052398 [TBL] [Abstract][Full Text] [Related]
37. Pemphigus vulgaris: recent advances in our understanding of its pathogenesis. Femiano F Minerva Stomatol; 2007 Apr; 56(4):215-23. PubMed ID: 17452959 [TBL] [Abstract][Full Text] [Related]
38. Usefulness of specific anti-desmoglein 1 and 3 enzyme-linked immunoassay and indirect immunofluorescence in the evaluation of pemphigus activity. Barnadas MA; Rubiales MV; Gich I; Gelpí C Int J Dermatol; 2015 Nov; 54(11):1261-8. PubMed ID: 25754029 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of desmoglein enzyme-linked immunosorbent assay (ELISA) in Indian patients with pemphigus vulgaris. Sharma VK; Prasad HR; Khandpur S; Kumar A Int J Dermatol; 2006 May; 45(5):518-22. PubMed ID: 16700783 [TBL] [Abstract][Full Text] [Related]
40. The mapping of linear B-cell epitope regions in the extracellular parts of the desmoglein 1 and 3 proteins: recognition of immobilized peptides by pemphigus patients' serum autoantibodies. Szabados H; Bősze S; Silló P; Kárpáti S; Hudecz F; Uray K J Pept Sci; 2013 Feb; 19(2):84-94. PubMed ID: 23297065 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]